KALV
KalVista Pharmaceuticals, Inc. Common Stock
$26.95
0.02%
+0.00
Notify me if price changes either direction
Buy KALV stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
1.4B
Enterprise value
1.4B
Trailing PE
-7.3021679389768
Forward PE
22.512472
PEG Ratio
0.13710192865018
Enterprise to EBITDA
-10.355
Enterprise to revenue
12.523
Price to book MRQ
-74.839728425731
Price to sales TTM
12.528909
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
114.5M
EBITDA
-138447008
Diluted EPS TTM
-3.94
Total Cash (MRQ)
285.0M
Current ratio (MRQ)
5.166
Operating Cash Flow (TTM)
-89319504
KALV trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
June 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
